Clinical Trials

500 enrolled

Lung Neoplasms, Neoplasms

NCT05119244 2026-05-06

ECP

150 enrolled

Phase NA Active not recruiting

Marijuana Abuse, Lung Neoplasms

NCT04222335 2026-04-29

LUNG-RESIST

80 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05306912 2026-04-29

KOBE

60 enrolled

Lung Neoplasms

NCT06620835 2026-04-29

OPTALK

Phase 2 Recruiting

45 enrolled

Lung Neoplasms

NCT00898313 2026-04-27

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

4,000 enrolled

Lung Neoplasms

NCT02630615 2026-04-24

Circulating Tumor Cells (CTC) in Lung Cancer

Active not recruiting

80 enrolled

BreastGynecologicThoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

NCT07163507 2026-03-18

RICEPS-2

Phase NA Not yet recruiting

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07465848 2026-03-12

PneumoTAV001

1,200 enrolled

Disease, Lung Neoplasms

NCT06996249 2026-03-03

DuTOC

Other solid neoplasmThoracic

12,000 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT07436858 2026-02-27

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

Phase 1 Not yet recruiting

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06016569 2026-02-12

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

3,200 enrolled

Phase EARLY_PHASE1 Recruiting

Lung Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

220 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06481813 2026-01-21

BREATHE

730 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT05267041 2025-11-21

ULYSSE

4,000 enrolled

Lung Neoplasms

NCT04968548 2025-11-04

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Active not recruiting

5,000 enrolled

Lung Neoplasms

NCT05020275 2025-08-15

RESISTYR

Active not recruiting

60 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06122077 2025-08-05

PROACT-LUNG

20,000 enrolled

Emphysema, Lung Neoplasms, Respiratory Distress Syndrome, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

NCT07087080 2025-07-31

Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules

350 enrolled

Phase NA Not yet recruiting

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

NCT07085429 2025-07-25

BCBPoumon

750 enrolled

Carcinoma, Bronchogenic, Lung Neoplasms

NCT05092009 2025-07-15

IPON-3

600 enrolled

Lung Neoplasms

NCT06896162 2025-07-11

PROGRESS

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00568490 2025-07-02

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers